Patients with PSE commonly present with several cardiovascular risk factors, requiring the avoidance of ASM that adversely affect biochemical markers of vascular disease, such as total cholesterol, lipoproteins, C-reactive protein (CRP), and total homocysteine, which may eliminate CBZ, PHT, phenobarbital, and primidone as options according to Mintzer et al. [73]. The gene discussed is CRP; the disease is photosensitive epilepsy.